Empagliflozin Fast Tracked for Improving Outcomes Following Myocardial Infarction
The effect of empagliflozin on all-cause mortality and hospitalization for heart failure will be evaluated in the in phase 3 EMPACT-MI study.
Diabetes
Novel Risk, Protective Factors for Type 2 Diabetes Identified
Mendelian randomization study identifies insomnia as possible risk factor for type 2 diabetes.
Pacemaker Need Higher in Patients With Type 2 Diabetes
Older age, longer diabetes duration, higher HbA1c tied to increased risk for pacemaker transplantation.
Moderate, Heavy Drinking Linked to Increased BP, Hypertension in T2DM
Odds of elevated blood pressure and stage 1, 2 hypertension increased with moderate drinking.
High Coronary Artery Calcium + Diabetes Even Riskier for Women
In adults with diabetes, high CAC score predicts CVD, total mortality more strongly in women than in men.
Higher Vitamin D Levels Linked to Lower Risk for Type 2 Diabetes
Relationship modified by overall sleep patterns, especially with daytime sleepiness.
Semglee Now Available for Patients With Diabetes
The long-acting human insulin analogue has an identical amino acid sequence to Lantus® (insulin glargine; Sanofi).
Updated ADA Guideline Recommends Combo Tx for Type 2 Diabetes With CKD
The 2020 ADA guideline update reflects evidence from recent major trials with cardiovascular and renal outcomes.
Urate-Lowering Therapy May Reduce Type 2 Diabetes Risk in Patients With Gout
Researchers investigated the association between gout, urate-lowering therapy use, and the risk of developing type 2 diabetes.
Dapagliflozin Reduces Kidney Failure Risk, Prolongs Survival in CKD
Dapagliflozin appears to preserve kidney function and improve survival in patients with chronic kidney disease whether or not they have type 2 diabetes.
-
Loading...
-
Loading...
Next post in Chronic Kidney Disease (CKD)
